Furthermore, a growing body of evidence has demonstrated that increased cyclin E1 1 levels are associated with malignancies, such as ovarian cancer (Guo et al., 2011), and elevated cyclin E1 expression is a poor prognostic factor in lung adenocarcinoma patients (Eymin and Gazzeri, 2010). This evidence concerns the gene CCNE1 and ovarian carcinoma.